Q2 and H1 FY27 earnings call scheduled for November 2, 2026

Board & Shareholder Meetings View source PDF Explain this filing

GRANULES · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+3.2%Reaction day

₹796.60

prior close

₹816.60

announcement price

In-mkt

timing

Nifty Smallcap 250market+1.1%+2.0% vs market

Pharmaceuticals peers, median of 174sector+1.2%+2.0% vs sector

On the reaction day the stock moved 2.0 pts more than Nifty Smallcap 250 and 2.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

-0.1

10m

-0.4

15m

-0.6

30m

-0.4

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+3.2+1.1+2.0+1.2+2.0

Next day

+4.5+3.3+1.1+3.1+1.4

+5.1pendingpending+4.7+0.4

—————

15d

—————

UpDownMarket · Nifty Smallcap 250Sector · Pharmaceuticals peers, median of 174Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Granules India will hold an analyst and investor earnings call at 6:00 PM IST on November 2, 2026, to discuss Q2 and first-half FY27 financial performance and business updates. Chairman and MD Krishna Prasad Chigurupati, Executive Director Priyanka Chigurupati, and CFO Mukesh Surana are scheduled to participate.

Likely market impact

The call may help investors assess quarterly performance and business updates, but the filing provides no financial figures or guidance.